Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3049233	u-orgah	— (—)	102	118	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of psychological development

8.54

24.93

1.0

1.2

—

Motor disorders, excluding more controls

13.33

19.26

1.1

1.3

—

Speech and linguistic disorders, excluding more controls

11.04

19.10

1.0

1.2

—

Mental retardation, excluding more controls

12.05

16.60

1.3

—

Epilepsy

5.91

16.41

1.3

1.1

—

Specific developmental disorder of motor function

9.59

15.82

1.1

1.4

—

Delayed milestone in childhood

6.25

15.77

1.2

—

Mixed specific developmental disorders

9.04

15.65

1.2

1.4

—

Any mental disorder

6.89

15.56

1.1

1.2

—

Lack of expected normal physiological development

8.47

15.19

1.1

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

5.05

14.36

1.2

1.1

—

Psychiatric diseases

6.41

14.30

1.1

1.2

—

Intestinal infectious diseases

4.45

13.75

1.1

1.2

—

Care involving use of rehabilitation procedures

5.11

13.42

1.2

—

Persons encountering health services for specific procedures and health care

4.13

12.23

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.90

11.64

1.2

—

Hyperkinetic disorders, excluding more controls

10.57

11.59

1.1

1.3

—

Convulsions, not elsewhere classified

7.00

11.22

1.4

1.2

—

Motor disorders

6.07

10.87

1.1

1.3

—

Speech and linguistic disorders

4.72

10.55

1.1

1.2

—

Procreative management

4.48

10.34

1.0

1.2

—

Medical observation and evaluation for suspected diseases and conditions

8.11

10.18

1.1

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

9.26

9.87

1.3

1.0

—

Focal epilepsy

5.87

9.57

1.4

1.1

—

Focal epilepsy, strict definition

5.93

9.11

1.4

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.87

8.85

1.1

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.05

8.66

1.1

1.2

—

Other reaction to severe stress, and adjustment disorders

10.00

8.64

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.15

8.39

1.2

—

Endocrine, nutritional and metabolic diseases

3.62

8.18

1.2

1.1

—

Disorders of refraction and accommodation

4.51

8.06

1.2

1.1

—

Headache

5.57

8.04

1.1

1.2

—

Specific development disorders of speech and language

5.58

7.91

1.0

1.3

—

Nausea and vomiting

4.35

7.69

1.2

—

Metabolic disorders

4.20

7.65

1.3

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

6.84

7.64

1.2

—

Neurological diseases

3.29

7.63

1.3

1.1

—

Wide developmental disorders, excluding more controls

8.30

7.49

1.1

1.3

—

Mental retardation

4.63

7.40

1.3

—

Mental retardation, wide definition

4.63

7.40

1.3

—

Specific development disorders of scholastic skills

13.25

7.33

1.2

1.1

—

Anxiety disorders, excluding more controls

7.96

7.28

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

6.65

7.16

1.2

1.0

—

Viral and other specified intestinal infections

4.49

7.14

1.1

1.2

—

Hypoglycaemia, other or unspecified

7.72

7.12

1.3

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.45

6.74

1.1

—

Astigmatism

5.73

6.57

1.3

1.2

—

Fever of other and unknown origin

4.81

6.26

1.1

1.2

—

Other problems related to primary support group, including family circumstances

3.64

6.09

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.47

6.03

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.25

5.94

1.1

—

Other strabismus

3.77

5.77

1.4

1.2

—

Diseases of the myoneural junction and muscle

12.88

5.58

1.2

1.1

—

Codes for special purposes

3.81

5.52

1.3

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

12.40

5.45

1.2

1.0

—

Strabismus

3.46

5.42

1.4

1.1

—

Disorders of other endocrine glands

3.13

5.42

1.2

1.1

—

Diseases of the eye and adnexa

3.10

5.41

1.1

—

Cardiomyopathy

11.26

5.28

1.1

1.0

—

Covid-19 confirmed case

5.00

5.25

1.1

1.2

—

Visual disturbances and blindness

3.75

5.08

1.3

1.2

—

Implicit Sepsis

3.57

5.02

1.2

1.1

—

Neurotic, stress-related and somatoform disorders

3.79

4.98

1.1

—

Anxiety disorders

3.78

4.95

1.1

—

Any gastric operation

2.99

4.94

1.2

1.1

—

GASTRO-related operations

2.99

4.94

1.2

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

4.59

4.77

1.5

1.2

—

General symptoms and signs

3.34

4.66

1.1

1.2

—

Provisional assignment of new diseases of uncertain etiology

3.49

4.60

1.2

—

Benzodiazepine use

3.56

4.59

1.4

1.2

—

Persons encountering health services in circumstances related to reproduction

2.76

4.59

1.2

—

Congenital malformations of the nervous system

8.25

4.57

1.2

1.5

—

Episodal and paroxysmal disorders

2.48

4.50

1.3

1.1

—

Disturbance of activity and attention

4.35

4.47

1.1

1.2

—

Malaise and fatigue

4.90

4.40

1.2

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.11

4.30

1.2

1.1

—

Nystagmus and other irregular eye movements

11.80

4.28

1.4

1.0

—

Pain, not elsewhere classified

8.89

4.27

1.4

1.0

—

Other functional intestinal disorders

2.91

4.12

1.3

1.1

—

Hyperkinetic disorders

3.57

4.11

1.1

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

3.24

4.10

1.1

—

All influenza

4.35

4.08

1.1

1.2

—

Complications of surgical and medical care, not elsewhere classified

3.59

4.08

1.1

1.0

—

Other disorders of eye and adnexa

6.44

3.98

1.3

—

Disorders of speech understanding and production

3.87

3.86

1.0

1.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.39

3.81

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.64

3.78

1.0

—

Gastro-oesophageal reflux disease

3.54

3.67

1.3

1.2

—

Complications of medical and surgical care

3.73

3.66

1.1

—

Cerebral palsy and other paralytic syndromes

5.63

3.65

1.6

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.03

3.65

1.0

1.1

—

Other and unspecified mental retardation

3.72

3.65

1.5

1.3

—

Visual disturbances

3.67

3.63

1.3

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

6.21

3.50

1.0

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.36

3.48

1.1

1.2

—

Complications of procedures, not elsewhere classified

3.93

3.47

1.1

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.33

3.36

1.2

—

All influenza (not pneumonia)

5.72

3.34

1.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

5.65

3.30

1.3

1.0

—

Other congenital malformations of brain

8.81

3.29

1.3

1.1

—

Influenza and pneumonia

2.25

3.25

1.2

1.1

—

Abnormalities of breathing

2.36

3.21

1.1

1.2

—

Wide developmental disorders

3.59

3.20

1.1

1.3

—

Neurological diseases, wide definition

2.74

3.17

1.1

—

Mood disorders, excluding more controls

6.08

3.16

1.1

1.0

—

Implicit viral Sepsis

5.00

3.05

1.3

—

Viral Sepsis

5.00

3.05

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

2.60

3.04

1.3

1.1

—

Haemolytic anaemias

10.03

2.98

1.0

2.0

—

Nonischemic cardiomyopathy

10.02

2.98

1.2

1.0

—

Open wound of ankle and foot

10.01

2.98

1.0

1.2

—

Certain infectious and parasitic diseases

2.30

2.94

1.3

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

9.81

2.94

1.0

—

Hypothyroidism and >3 levothyroxin purchases

6.71

2.93

1.0

—

Hypothyroidism, levothyroxine purchases

6.71

2.93

1.0

—

Any reimbursement code in KELA

2.58

2.87

1.1

—

Abnormalities of gait and mobility

5.39

2.87

1.1

1.3

—

Conjunctivitis (acute, non atopic)

2.68

2.86

1.3

1.2

—

Diseases of oesophagus, stomach and duodenum

2.63

2.80

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.23

2.77

1.1

1.2

—

Asthma (mode)

3.66

2.76

1.1

1.0

—

Cardiomyopathies, Primary/intrinsic

8.34

2.75

1.2

1.0

—

Cardiomyopathy (excluding other)

8.34

2.75

1.2

1.0

—

Disturbances of skin sensation

8.34

2.75

1.0

1.2

—

Cerebral palsy

5.04

2.73

1.6

1.0

—

2.91

2.73

1.5

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.91

2.73

1.5

1.1

—

Acute tubulo-interstitial nephritis

2.75

2.71

1.4

1.1

—

Visual impairment including blindness (binocular or monocular)

6.01

2.70

1.2

1.1

—

Hypothyroidism (congenital or acquired)

5.75

2.69

1.0

—

Use of hypnotics and sedatives

2.57

2.66

1.4

1.2

—

Asthma

3.58

2.66

1.1

1.0

—

Other and unspecified tonsillitis

3.01

2.64

1.1

—

Asthma, excluding more controls

3.55

2.63

1.1

1.0

—

Persons encountering health services in other circumstances, wide

2.04

2.59

1.2

1.1

—

Other disorders starting during childhood or adolescence

2.64

2.58

1.3

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.15

2.56

1.0

1.2

—

Symptoms and signs concerning food and fluid intake

5.45

2.54

1.3

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.07

2.54

1.2

1.1

—

Implicit bacterial Sepsis

5.50

2.52

1.2

1.1

—

Acute upper respiratory infections

2.54

2.50

1.1

—

Disorders of conjunctiva

2.15

2.40

1.3

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6.80

2.39

1.2

1.0

—

Examination and observation for other reasons

4.05

2.39

1.0

—

Other pulmonary diagnosis

3.34

2.38

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

3.34

2.38

1.1

1.0

—

COPD differential diagnosis

3.34

2.38

1.1

1.0

—

ILD differential diagnosis

3.34

2.38

1.1

1.0

—

Persons encountering health services for examination and investigation

3.76

2.38

1.1

1.0

—

Other arrhythmias

3.45

2.38

1.0

1.1

—

Keratitis

6.25

2.37

1.0

—

Concussion

2.66

2.37

1.1

—

Otalgia

4.12

2.36

1.0

1.1

—

Hypothyroidism, other/unspecified

2.90

2.35

1.1

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.90

2.35

1.1

1.0

—

Conjunctivitis

2.15

2.30

1.3

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.31

2.29

1.4

1.1

—

Other diseases of the respiratory system

4.62

2.27

1.2

1.1

—

Other respiratory disorders and diseases

4.62

2.27

1.2

1.1

—

All pneumoniae

2.00

2.24

1.3

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.55

2.24

1.2

1.0

—

Birth asphyxia

5.66

2.22

1.6

1.4

—

Other medical care

4.51

2.22

1.2

1.1

—

Diseases of the respiratory system

3.47

2.22

1.1

1.0

—

Immunodeficiencies

5.57

2.21

1.0

1.6

—

Symptoms and signs involving speech and voice

5.56

2.21

1.0

1.1

—

Other anxiety disorders

3.88

2.21

1.1

1.0

—

Nerve, nerve root and plexus disorders

3.59

2.17

1.1

1.0

—

Acute pharyngitis

3.31

2.16

1.1

—

COPD/asthma related infections

2.50

2.15

1.1

—

COPD/asthma/ILD related infections

2.50

2.15

1.1

—

Amblyopia ex anopsia

4.30

2.15

1.5

1.4

—

Disorders of sclera, cornea, iris and ciliary body

3.68

2.15

1.0

1.1

—

Nutritional anaemias

3.24

2.11

1.0

1.2

—

Certain conditions originating in the perinatal period

2.30

2.10

1.4

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.95

2.10

1.1

—

Artificial joint operation, meniscal resection

5.54

2.05

1.0

—

Dialysis, with operation codes

4.00

2.04

1.0

1.3

—

Certain disorders involving the immune mechanism

4.00

2.04

1.0

1.3

—

Bacterial pneumonia, not elsewhere classified

4.09

2.03

1.2

1.1

—

Allergic conjunctivitis

2.86

2.03

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.90

2.00

1.1

1.4

—

Bacterial Sepsis

3.46

2.00

1.1

1.3

—

Autoimmune diseases related-to ILD

2.66

2.00

1.1

—

Mouth breathing

2.28

1.97

1.1

1.2

—

Transplanted organ and tissue status

3.34

1.96

1.0

1.3

—

Other and unspecified iron deficiency

3.33

1.96

1.0

1.2

—

Asthma (only as main-diagnosis)

3.22

1.95

1.1

1.0

—

STROKE

4.96

1.93

1.0

—

Otitis media, unspecified

2.47

1.93

1.3

1.1

—

Asthma (only as main-diagnosis), excluding more controls

3.18

1.93

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.34

1.92

1.0

1.2

—

Abnormal serum enzyme levels

4.49

1.92

1.4

1.0

—

Depression or dysthymia

4.20

1.92

1.2

1.0

—

Abnormal findings on examination of blood, without diagnosis

3.27

1.91

1.3

1.1

—

Cerebrovascular diseases

3.91

1.90

1.0

1.1

—

Bronchitis

2.24

1.88

1.1

—

Other disorders of skin and subcutaneous tissue

3.21

1.87

1.1

1.2

—

Infections, IBD-co-morbidities

4.55

1.85

1.0

—

Hard cardiovascular diseases

3.85

1.84

1.0

1.1

—

Hypermetropia

3.53

1.83

1.0

1.2

—

Explicit Sepsis

2.61

1.82

1.1

1.2

—

Heterophoria

4.17

1.82

1.0

1.3

—

Nonsuppurative otitis media

2.31

1.82

1.2

1.1

—

Gastrointestinal diseases

1.98

1.80

1.3

1.1

—

Congenital malformations of the circulatory system

2.12

1.80

1.2

—

Intermittent heterotropia

3.05

1.80

1.4

1.3

—

Allergic asthma (mode)

4.09

1.79

1.0

—

Allergic asthma (mode), excluding more controls

4.09

1.79

1.0

—

Heart failure, not strict

2.55

1.76

1.0

1.2

—

Inflammatory diseases of female pelvic organs

4.19

1.75

1.2

1.0

—

Anaemias

2.56

1.75

1.1

1.2

—

Exclusions for E4_PCOS_BROAD

2.44

1.75

1.0

1.2

—

Cardiac arrhythmias

2.42

1.74

1.0

1.1

—

Irregular menses

4.06

1.73

1.2

1.0

—

Mild mental retardation

3.86

1.71

1.0

1.1

—

Other headache syndromes

3.85

1.71

1.0

1.1

—

Bacterial pneumoniae

3.32

1.71

1.2

1.1

—

Acute sinusitis

3.29

1.71

1.0

1.2

—

Dizziness and giddiness

2.71

1.71

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.85

1.70

1.3

1.1

—

Iron deficiency anaemia

2.89

1.70

1.0

1.2

—

All anxiety disorders

2.68

1.69

1.1

1.0

—

Intracranial trauma

2.24

1.67

1.1

—

Cerebrovascular diseases (FINNGEN)

3.97

1.67

1.0

—

Other nutritional deficiencies

2.61

1.67

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.82

1.64

1.1

1.0

—

Abdominal and pelvic pain

1.86

1.62

1.1

1.2

—

Other diseases of pleura

3.13

1.62

1.2

1.3

—

Inflammatory bowel disease

3.57

1.61

1.2

1.1

—

Other congenital malformations

2.27

1.53

1.1

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

1.78

1.52

1.3

1.1

—

Other postsurgical states

3.34

1.52

1.2

1.4

—

Other diseases of blood and blood-forming organs, wide

3.33

1.52

1.0

1.1

—

Renal tubulo-interstitial diseases

1.99

1.50

1.4

1.1

—

2.05

1.49

1.1

—

Emotional disorders starting during childhood or adolescence

2.84

1.49

1.0

1.1

—

Sleep apnoea, including avohilmo

2.67

1.48

1.0

1.1

—

Dental caries 3, only avohilmo

0.41

1.47

1.0

1.2

—

Other endocrine disorders

2.07

1.47

1.5

1.2

—

Hypopituitarism

2.73

1.43

1.0

1.2

—

Bacterial pneumonia (organism specified)

2.73

1.42

1.2

1.3

—

Disorders of the thyroid gland

2.18

1.42

1.1

1.0

—

Short stature, not elsewhere classified

2.12

1.41

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.67

1.40

1.2

1.0

—

Pneumonia, organism unspecified

1.81

1.39

1.4

1.1

—

Cardiovascular diseases

1.69

1.37

1.0

1.2

—

Oral corticosteroids

2.27

1.37

1.2

1.1

—

Childhood asthma (age<16)

3.05

1.36

1.2

1.0

—

Childhood asthma (age<16), excluding more controls

3.05

1.36

1.2

1.0

—

Dental caries 3 and operation codes

0.44

1.36

1.0

1.2

—

Impetigo

2.95

1.36

1.0

1.3

—

Nephropathy related operations

2.94

1.36

1.0

1.3

—

Other septicaemia

2.37

1.35

1.1

—

Aplastic and other anaemias

2.59

1.34

1.2

1.3

—

Childhood allergy (age < 16)

1.85

1.34

1.3

1.1

—

Diseases of the ear and mastoid process

1.79

1.32

1.1

—

Other neurological diseases

2.47

1.32

1.4

1.1

—

Hypoplasia of dental enamel , including avohilmo

0.00

1.32

0.0

1.3

—

Other diseases of intestines

1.66

1.32

1.3

1.1

—

Cough

2.03

1.30

1.2

—

Other disorders originating in the perinatal period

2.38

1.30

2.0

1.1

—

L04AA Selective immunosuppressants

2.78

1.28

1.0

1.3

—

Type 2 diabetes

2.97

1.27

1.2

1.0

—

Septicaemia

2.26

1.25

1.1

—

Acute suppurative otitis media

1.98

1.22

1.1

—

Obesity due to excess calories

2.63

1.21

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

2.17

1.20

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.67

1.20

1.2

—

Polycystic ovarian syndrome, consortium definition

2.74

1.18

1.2

1.0

—

Other and unspecified anaemias

2.55

1.17

1.2

1.3

—

Other anaemias

2.54

1.16

1.2

1.3

—

Dental caries 3

0.49

1.16

1.0

1.2

—

Constipation

1.71

1.13

1.4

1.1

—

Injuries to the ankle and foot

1.85

1.12

1.1

1.2

—

Renal failure

2.40

1.09

1.0

1.3

—

Migraine without aura

2.38

1.09

1.2

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.81

1.07

1.0

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.73

1.05

1.1

1.2

—

Persons with potential health hazards related to communicable diseases

1.74

1.04

1.1

1.2

—

Suppurative and unspecified otitis media

1.84

1.01

1.1

—

Congenital malformations of heart and great arteries

1.76

0.99

1.2

—

Genitourinary diseases

1.57

0.98

1.3

1.2

—

Other disorders of penis

2.18

0.98

1.0

1.2

—

Sleep apnoea

2.39

0.97

1.0

1.1

—

Diseases of middle ear and mastoid

1.76

0.96

1.1

—

Other heart diseases, wide

1.60

0.94

1.1

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.89

0.94

1.1

—

L04AD Calcineurin inhibitors

2.22

0.93

1.0

1.2

—

Obesity

2.20

0.93

1.0

1.1

—

Obesity and other hyperalimentation

2.20

0.93

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

1.98

0.91

1.0

1.3

—

Inflammatory bowel disease treatment related agents

1.64

0.90

1.1

1.2

—

Dyspnoea

1.82

0.89

1.2

1.1

—

Intracranial injury

1.74

0.89

1.1

1.2

—

Noninfective enteritis and colitis

1.75

0.83

1.1

1.2

—

Congenital malformations of genital organs

1.86

0.81

1.0

1.3

—

Depression

1.72

0.80

1.1

1.0

—

Acute bronchitis

1.70

0.80

1.3

1.2

—

Hypoplasia of dental enamel, including avohilmo

0.00

0.79

0.0

1.4

—

Tonsillectomy and adenotomy

1.53

0.78

1.2

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.78

0.0

1.2

—

Contact with and exposure to communicable diseases

1.66

0.77

1.1

1.2

—

Symptoms and signs involving the urinary system

1.70

0.75

1.0

1.2

—

Other disorders of ear

1.63

0.75

1.0

1.2

—

Respiratory distress of newborn

1.68

0.75

1.1

1.2

—

Acute laryngitis and tracheitis

2.05

0.74

1.2

1.1

—

Chronic diseases of tonsils and adenoids

1.53

0.73

1.2

—

Other viral diseases, not elsewhere classified

1.63

0.73

1.1

1.2

—

Exposure to other specified factors

1.61

0.70

1.1

1.2

—

Other and unspecified dermatitis

1.85

0.68

1.0

1.1

—

Dental caries 1

0.61

0.67

1.0

1.2

—

Dental caries, including avohilmo

0.61

0.67

1.0

1.2

—

Dental caries 1, only avohilmo

0.59

0.67

1.0

1.2

—

Pain (limb, back, neck, head abdominally)

1.48

0.66

1.1

1.2

—

Codeine or tramadol medication

1.85

0.66

1.2

1.0

—

Atopic dermatitis, strict definition

1.55

0.66

1.5

1.1

—

Crossbite

1.62

0.66

1.0

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.79

0.66

2.0

1.1

—

ILD medications: immunosuppressive drugs

1.63

0.66

1.2

—

Disorders of skin appendages

1.78

0.66

1.0

—

Effects of foreign body entering through natural orifice

1.72

0.64

1.0

1.2

—

Hypothyroidism, strict autoimmune

1.74

0.63

1.0

1.1

—

Mood [affective] disorders

1.64

0.63

1.1

1.0

—

Mood disorders

1.64

0.62

1.1

1.0

—

Other noninfective gastroenteritis and colitis

1.63

0.62

1.1

1.2

—

Accidents

0.60

0.61

1.0

1.2

—

Other external causes of accidental injury

0.60

0.61

1.0

1.2

—

Chromosomal abnormalities, not elsewhere classified

1.67

0.61

1.0

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1.60

0.61

1.9

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.57

0.60

1.1

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.60

0.0

1.2

—

Diseases of the skin and subcutaneous tissue

1.41

0.60

1.1

—

Anomalies of dental arch relationship, including avohilmo

1.53

0.59

1.0

1.2

—

Atopic dermatitis, strict definition with reimbursement

1.52

0.58

1.5

1.1

—

Dental pulpitis 2

0.62

0.57

1.0

1.2

—

Dental pulpitis 2, only avohilmo

0.62

0.57

1.0

1.2

—

Other and unspecified effects of external causes

1.62

0.55

1.2

1.3

—

Congenital malformations of cardiac septa

1.54

0.55

1.2

—

1.49

0.54

1.1

1.2

—

Atrial septal defect

1.53

0.52

1.3

1.2

—

Other viral diseases

1.51

0.52

1.1

1.2

—

Other disorders of urethra and urinary system

1.50

0.51

1.2

—

Arthropathies

0.61

0.50

1.4

1.2

—

Dental caries 2 and operation codes

1.44

0.50

1.0

1.2

—

Asthma-related infections

1.46

0.50

1.1

1.2

—

Asthma, hospital admission 2, infections

1.46

0.50

1.1

1.2

—

Acute bronchiolitis

1.50

0.49

1.1

1.2

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.49

0.48

1.3

1.2

—

Dental caries

1.51

0.48

1.0

1.2

—

First line medication for Crohn's disease

1.36

0.47

1.1

1.2

—

Dental caries 1 and operation codes

0.68

0.45

1.0

1.2

—

Exposure to unspecified factor

1.36

0.43

1.0

1.2

—

Dentinal caries

1.55

0.42

1.0

1.3

—

Other antidepressants

1.53

0.42

1.2

1.0

—

Chronic lower respiratory diseases

1.28

0.40

1.1

1.2

—

Dermatitis and eczema

1.31

0.40

1.3

1.1

—

Dental caries 2 and operation codes, only avohilmo

1.40

0.39

1.0

1.2

—

Other diseases of upper respiratory tract

1.30

0.39

1.1

1.2

—

Valvular heart disease excluding rheumatic fever

1.40

0.38

1.0

1.2

—

Used for control exclusion in common control thyroid runs

1.29

0.38

1.1

1.2

—

Type 1 diabetes

1.39

0.38

1.2

—

Gingivitis and periodontal diseases

0.63

0.37

1.2

1.3

—

Dermatitis

1.35

0.37

1.0

1.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

0.64

0.37

1.2

—

Atopic dermatitis

1.35

0.37

1.4

1.1

—

Diseases of male genital organs

1.39

0.36

1.0

1.2

—

Dental caries 2

1.35

0.36

1.0

1.2

—

Infections of the skin and subcutaneous tissue

1.28

0.36

1.0

1.2

—

Crowding of teeth, including avohilmo

1.46

0.36

1.0

1.2

—

Other acute lower respiratory infections

1.38

0.36

1.1

1.2

—

Other fall from one level to another

1.36

0.34

1.2

—

Pain in throat and chest

1.31

0.33

1.0

—

Deposits [accretions] on teeth

1.29

0.32

1.2

1.3

—

Other joint disorders

0.70

0.32

1.1

1.2

—

Hypertensive diseases

1.32

0.31

1.0

1.3

—

Hypertension

1.32

0.31

1.0

1.3

—

Asthma/COPD (KELA code 203)

1.29

0.30

1.1

1.2

—

Vasomotor and allergic rhinitis

1.28

0.30

1.0

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.25

0.29

1.1

1.2

—

Congenital malformations and deformations of the musculoskeletal system

1.22

0.28

1.1

1.2

—

Neoplasms

0.77

0.28

1.2

—

Pain in limb

1.30

0.28

1.1

1.2

—

Diabetes, varying definitions

1.33

0.27

1.2

—

Diabetes mellitus

1.33

0.27

1.2

—

Cystitis

0.69

0.27

1.0

1.2

—

Diabetes medication

0.66

0.26

1.2

—

ILD medications

1.23

0.24

1.1

1.2

—

Migraine

1.33

0.23

1.2

1.0

—

Sub-endpoint used in defining T1D endpoints

1.33

0.23

1.2

—

Persons encountering health services in other circumstances

1.28

0.23

1.2

—

Dental caries 2, only avohilmo

1.27

0.22

1.0

1.2

—

Diabetic retinopathy, excluding more controls

0.00

0.22

0.0

1.1

—

Diseases of the digestive system

1.22

0.22

1.2

—

Diabetic retinopathy

0.00

0.22

0.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.21

0.0

1.1

—

Otitis externa, unspecified

0.00

0.21

0.0

1.0

—

Other disorders of bone

0.00

0.21

0.0

1.0

—

Unspecified mental disorder

0.00

0.21

0.0

1.1

—

Poisoning by drugs, medicaments and biological substances

0.00

0.21

0.0

1.1

—

Varicose veins

0.00

0.21

0.0

1.0

—

Antihypertensive medication - note that there are other indications

1.25

0.21

1.1

1.2

—

Chronic sinusitis

0.00

0.21

0.0

1.0

—

Other juvenile arthritis

0.00

0.20

0.0

1.4

—

Juvenile arthritis (FINNGEN)

0.00

0.20

0.0

1.1

—

Migraine with aura

0.00

0.20

0.0

1.1

—

Urticaria and erythema

1.25

0.20

1.0

1.3

—

Hypertensive diseases (excluding secondary)

1.16

0.19

1.0

1.3

—

Other heart diseases

1.23

0.19

1.1

1.2

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.15

0.19

1.0

1.2

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.15

0.19

1.0

1.2

—

Personal history of other diseases and conditions

1.15

0.19

1.3

1.2

—

Sleep disorders (combined)

1.21

0.18

1.1

1.2

—

Dental caries 1 and operation codes, only avohilmo

0.74

0.17

1.0

1.3

—

Malignant neoplasm

0.76

0.17

1.2

—

Malignant neoplasm, wide definition for exclusion

0.72

0.17

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

0.72

0.17

1.2

—

Septal defects

1.17

0.16

1.3

1.2

—

Other soft tissue disorders, not elsewhere classified

1.18

0.16

1.1

1.2

—

Other diseases of hard tissues of teeth

0.75

0.15

1.2

—

Injuries to the wrist and hand

1.16

0.15

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.16

0.14

1.1

1.2

—

Autoimmune diseases excluding thyroid diseases

1.16

0.14

1.1

1.2

—

Soft tissue disorders

0.85

0.14

1.2

—

External causes of morbidity and mortality

0.82

0.14

1.0

1.2

—

Benign neoplasms

1.16

0.10

1.1

1.2

—

Urticaria

1.14

0.10

1.0

1.3

—

Other congenital malformations of the digestive system

1.10

0.09

1.0

1.3

—

L04AX Other immunosuppressants

1.09

0.09

1.2

—

Dentofacial anomalies [including malocclusion]

1.08

0.09

1.0

1.2

—

Dorsalgia

1.04

0.09

1.0

1.1

—

Second line medication for Crohn's disease

1.04

0.09

1.2

1.1

—

Asthma, including avohilmo

1.11

0.09

1.1

1.2

—

Finngen Rheumatological endpoints

1.07

0.09

1.5

1.0

—

D07AA Corticosteroids, weak (group I)

1.11

0.09

1.2

—

Pollen allergy

1.10

0.09

1.0

1.2

—

Asthma, hospital admissions , main diagnosis only

1.13

0.08

1.1

1.2

—

Haemorrhagic and haematological disorders of fetus and newborn

1.02

0.08

1.3

1.2

—

0.78

0.08

1.0

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.85

0.08

1.2

—

Dorsopathies

1.10

0.08

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.82

0.08

1.2

—

Allergic rhinitis

1.02

0.07

1.0

1.2

—

Dental operations

1.07

0.07

1.2

—

Benign neoplasms

1.08

0.07

1.1

—

Asthma (diagnoses ohter than nonallergic)

1.12

0.07

1.1

1.2

—

Injuries to the knee and lower leg

0.89

0.06

1.1

1.2

—

Diseases of oral cavity, salivary glands and jaws

0.91

0.06

1.2

—

Diseases of the musculoskeletal system and connective tissue

0.92

0.05

1.2

—

Fall on same level

0.93

0.03

1.1

1.2

—

Other diseases of urinary system

1.06

0.00

1.1

1.2

—

Falls/tendency to fall

1.01

0.00

1.1

1.2

—

Injuries to the head

1.03

0.00

1.1

1.2

—

Autoimmune diseases

1.04

0.00

1.1

1.2

—

Other infections specific to the perinatal period

0.00

0.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.0

1.2

—

Disorders of vitreous body and globe

0.00

0.0

1.0

—

Other bacterial diseases

0.95

0.00

1.1

1.2

—

Lactose intolerance

0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

0.0

1.2

—

Prolonged pregnancy

0.00

0.0

1.2

—

Poisoning by medicine

0.00

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.0

1.0

—

Nasal polyp

0.00

0.0

1.0

—

Melanocytic naevi of trunk

0.00

0.0

1.0

—

Recurring oral aphthae

0.00

0.0

1.1

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.0

1.0

—

Melanocytic naevi of trunk

0.00

0.0

1.0

—

Functional dyspepsia

0.00

0.0

1.0

—

Other respiratory diseases principally affecting the interstitium

0.00

0.0

1.2

—

Emergency coronary revascularization (for ACS)

0.00

0.0

1.1

—

Other congenital malformations of ear

0.00

0.0

1.2

—

Heartburn

0.00

0.0

1.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.2

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.2

—

Other osteochondrodysplasias

0.00

0.0

1.2

—

Other congenital malformations of kidney

0.00

0.0

1.2

—

Pneumonia derived septicemia

0.00

0.0

1.0

—

Contusion of ankle

0.00

0.0

1.0

—

Injuries to the elbow and forearm

0.97

0.00

1.2

1.1

—

Contusion of other and unspecified parts of foot

0.00

0.0

1.0

—

Foreign body on external eye

0.00

0.0

1.2

—

Other and unspecified injuries of lower leg

0.00

0.0

1.0

—

Injury, poisoning and certain other consequences of external causes

0.98

0.00

1.0

1.2

—

Open wound of head

1.00

0.00

1.2

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.0

1.2

—

Contact with other hot metals

0.00

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

1.2

—

Unspecified fall

0.96

0.00

1.0

1.2

—

Contact with other sharp object(s)

0.00

0.0

1.0

—

Birth trauma

0.00

0.0

1.1

—

1.01

0.00

1.3

1.2

—

Benign lipomatous neoplasm

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.7

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.6

—

Chondropathies

0.00

0.0

1.0

—

Osteomyelitis

0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

0.0

1.0

—

Kela-code for severe mental illness

0.00

0.0

1.0

—

Fall involving bed

0.00

0.0

1.0

—

Café au lait spots

0.00

0.0

1.8

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.0

1.1

—

Other cataract

0.00

0.0

1.0

—

Other specific joint derangements/joint disorders

0.84

0.00

1.2

1.1

—

Congenital malformations of spine and bony thorax

0.00

0.0

1.2

—

Other diseases of lip and oral mucosa

0.00

0.0

1.0

—

Exclusion endpoint for supernumerary teeth

0.00

0.0

1.1

—

Pyogenic arthritis

0.00

0.0

1.0

—

Scoliosis

0.00

0.0

1.0

—

Torsion of testis

0.00

0.0

1.2

—

Pediculosis, acariasis and other infestations

0.00

0.0

1.2

—

Neonatal jaundice from other and unspecified causes

0.91

0.00

1.4

1.2

—

Injury of eye and orbit

0.00

0.0

1.1

—

Dental operations, only avohilmo

0.89

0.00

1.1

1.2

—

Selective serotonin reuptake inhibitors

0.97

0.00

1.2

1.0

—

Other disorders of teeth and supporting structures

0.00

0.0

1.0

—

Hyperlipidaemia, other/unspecified

0.00

0.0

1.0

—

Scabies

0.00

0.0

1.2

—

Other disorders of veins

0.00

0.0

1.1

—

Lactose intolerance, other/unspecified

0.00

0.0

1.0

—

Other disorders of optic disc

0.00

0.0

1.2

—

Stomatitis and related lesions

0.00

0.0

1.0

—

Pneumococcal septicemia

0.00

0.0

1.1

—

Acute alcohol intoxication, ICD10

0.00

0.0

1.0

—

Other enthesopathies

0.00

0.0

1.0

—

Other dorsopathies, not elsewhere classified

0.91

0.00

1.0

1.1

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Idiopathic thrombocytopenic purpura

0.00

0.0

1.2

—

Glaucoma

0.00

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.0

1.0

—

Migraine with aura and triptan purchases

0.00

0.0

1.1

—

Acute alcohol intoxication

0.00

0.0

1.0

—

Senile cataract

0.00

0.0

1.0

—

Other/unspecified dorsalgia

0.00

0.0

1.3

—

Other sleep disorders

0.00

0.0

1.0

—

Infectious mononucleosis

0.00

0.0

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

0.0

1.2

—

Volume depletion

0.00

0.0

1.0

—

Diabetic retinopathy, strict definition

0.00

0.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.6

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.7

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of breast

0.00

0.0

1.0

—

Internal derangement of knee

0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative

0.00

0.0

1.0

—

Coronary revascularization (ANGIO or CABG)

0.00

0.0

1.2

—

Irritable bowel syndrome

0.00

0.0

1.0

—

Any event in cancer register

0.93

0.00

1.2

1.1

—

Varicella [chickenpox]

0.00

0.0

1.1

—

Bleeding

0.91

0.00

1.2

—

Chronic laryngitis and laryngotracheitis

0.00

0.0

1.0

—

Cleft lip, lip and palate or palate

0.00

0.0

1.0

—

Mandibular prognathia

0.00

0.0

1.2

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

-0.00

0.0

1.2

—

Pain associated with micturition

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Organic acids panel - Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS